AZD5363 when combined with weekly paclitaxel.
D3610C00002
Phase 2 small_molecule completed
Quick answer
AZD5363 when combined with weekly paclitaxel. for Advanced or Metastatic Breast Cancer is a Phase 2 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Advanced or Metastatic Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed